Are you a current customer or distributor of IB10?
Would you like to learn more about IB10 technology and products?
The information provided in this quote request will be forwarded to the distributors responsible for your area. No in vitro diagnostic (IVD) product based on the Nexus IB10 technology is available for distribution in, or delivery to, the United States of America or Canada. Further, no IVD product based on the Nexus IB10 technology is approved for use in the United States of America or Canada.
SPHINGOTEC GROUP
COMBINING INNOVATIVE BIOMARKER WITH OUTSTANDING TECHNOLOGY
LATEST NEWS
sphingotec expands leadership team and appoints Achim Plum as Managing Director and Chief Commercial Officer
sphingotec’s endothelial function biomarker bio-ADM® improves risk stratification of sepsis patients at ICUs
Bioactive Adrenomedullin, measured with sphingotec’s bio-ADM® assay plays a key role in septic shock patients as top-line results of AdrenOSS-2 Phase II Study indicate
Novel data on sphingotec’s biomarkers for acute and critical care settings to be presented at AKI & CRRT 2020